Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer: e91666
Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer: e91666
About this item
Full title
Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer: e91666
Author / Creator
Journal title
PloS one, 2014-03, Vol.9 (3)
Language
English
Formats
More information
Scope and Contents
Contents
We aimed to identify a prostate cancer DNA hypermethylation microarray signature (denoted as PHYMA) that differentiates prostate cancer from benign prostate hyperplasia (BPH), high from low-grade and lethal from non-lethal cancers. This is a non-randomized retrospective study in 111 local Asian men (87 prostate cancers and 24 BPH) treated from 1995...
Alternative Titles
Full title
Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer: e91666
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1512322335
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1512322335
Other Identifiers
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0091666
How to access this item
Log in as a Library member
